MITF and melanoma: We observed a similar positive correlation between MITF and CDK2 in melanoma patients (Fig 6B), where melanoma exhibited the greatest and most significant correlation (Pearson r = 0.6, Padj = 3.3 e−53) among the available cancers (Dataset EV6).